-Schematic diagram of a wearable artificial kidney. The access and connector system consists of the vascular access (A), the tubings (B) and the entrance to the wearable kidney (e).
In Figure 1 , a wearable artificial kidney in its simplest design is represented. It is constituted by two essential parts, the access system and the artificial kidney itself. The access and connection system is a neglected aspect, and needs to be reconsidered carefully. and the wearable kidney, and this is symbolized by "B"; finally, the entrance to the wearable kidney is symbolized by "C". Blood flow may be intermittent or continuous, high or low. Blood displacement must be produced by the use of a pumping system, either the interposition of an artificial pump, or a natural pump such as the heart.
As far as the vascular access is concerned, a substantial number of possibilities should be considered: endogenous arterio-venous connections, exogenous A-V connections (shunts, Goretex or PTFE), indwelling catheters in non-prepared vessels (either arterial and/or venous), or the Haemasite button. There could be other less current or not yet invented possi bi Iities.
The connection between the patient and the device should necessarily be made up by tubes, with or without associated pumping systems. Pumps may not always seem essential but could result in a more stable and efficient blood delivery.
Specific attention should be given to the entrance to the dialyzer. It should be stressed that most currently used connections in conventional hemodialysis link tubings and dialyzer with a screw system, which may turn out to be awkward and unsafe in the setting of the wearable artificial kidney. Perhaps we could learn here from CAPO, where simple and efficient connectors, mainly based on the Luer-Lock principle, are in use (2).
A special aspect of the transition between "A" and "B", i.e, between the patient's vessels and the tubings, should also be considered. Here, one could use either a single or a two needle set-up. In conventional hemodialysis, the pressure-pressure single needle system has turned out to be a safe and efficient strategy, with a protective effect on the vascular access (3). This method also allows perfect ultrafiltration control (4) . We think that, after the necessary miniaturisation, the single needle system, as described by our group, should be considered for the wearable artificial kidney.
Several materials can be used for the creation of the access. They should be biocompatible materials
Access and connection system
The principle of the access system can be subdivided into three items: first, an entrance to the vascular system of the patient is needed, and this corresponds to the location "A" in Figure 1 ; second, blood flow should be realized between the patient One of the aims of the nephrological world is to develop an ambulatory artificial kidney, although attempts have remained fragmentary. Recent advances have resulted in important steps forward, as appeared at the ESAO congress in Avignon (1), but this topic remains subjected to an important number of existing and potential pitfalls.
Therefore it may be interesting to review first the definitions and anatomy of the presently available modalities of wearable artificial kidneys.
in which molecules like heparin or anticoagulant prostaglandins could be incorporated. Other alternatives are metals or ceramics. At present it is virtually unknown what is the most perfect solution, and intensive research will be necessary in this field. It is predictable that we will finally end up with a combination of several materials.
Lastly, one should consider the site of the system. A vascular access at the head-neck region (jugular vein, either alone or in combination with the carotid artery), at the truncus (either the subclavian vessels that are sufficiently superficial or any other vessel that will need superficialisation), or at the limbs (making use of femoral, radial, brachial and/or ulnar vessels), could be created.
In terms of the possible position of the wearable kidney, the most realistic place is probably extracorporeal, around the trunk and fixed to the body by means of a belt. Whether or not this solution is feasible depends largely on the volume. Once a sufficient miniaturisation is realized without loss in efficiency, one can start dreaming of an implantable device.
Artificial kidney
We would now like to concentrate on the artificial kidney itself. One should probably rely on the principles of existing systems, but it must be borne in mind that the natural kidney consists of glomeruli and tubules, and that the wearable artificial kidney should, as far as possible, replace both aspects of renal physiology.
Two possibilities presently available are diffusive and convective dialysis. Dialysate can either be replaced or regenerated. Ultrafiltration necessitates the administration of substitution fluid, either parenteral or by mouth. Ultrafiltrate can however be regenerated as well.
Existing systems
Making use of the afore-mentioned possibilities, several steps have been made in the development of a wearable artificial kidney during the last few years (Tab. I) (5) (6) (7) (8) (9) (10) (11) (12) (13) , starting with the development of the WAK-system in the late sixties by Kolff (this system is rather more portable than wearable (5)), and ending with successful attempts of miniaturisation by lssautier (10) and by Murisasco (11), and the development of artificial tubules by Aebisher (12) and Falkenhagen (13) .
The development of these new systems has been accompanied by expected and unforeseen problems, and raises new questions.
Pitfalls Vascular access
To date our personal experience with central venous catheter dialysis exceeds more than 800 catheterisa- (14) (15) and it is beyond any doubt that, according to this experience, thrombosis or clotting can be expected to become one of the most frequent complications in a wearable set-up. Clotting of the catheter necessitates at least its replacement; thrombosis can mean permanent loss of the vessel and a number of troublesome complications, including pulmonary embolisms. The use of new, less thrombogenic materials, the incorporation of anti-clotting substances into these polymers, and the parenteral or peroral administration of anticoagulants may, at least in part, resolve these problems although at the same time they may create new pitfalls. The use of Hickmann-Broviac catheter types (16) is a possible solution, but present dialysis experience is not sufficient to determine whether these catheters can be used continuously or semicontinuously for several years. Another frightening complication is sepsis. Withdrawal of the catheter material will become mandatory in many of these cases, which means temporary arrest of the wearable artificial kidney system. Another important point to mention is the potential inconvenience for the patient, especially if we are dealing with vascular access sites such as the jugular or the femoral region.
Finally, one should be aware about the possibility of leaks developing in either the tubing, catheter material, or the vessels at the insertion site. The latter complication may occur most frequently in an arterial insertion and may be one of the reasons why a venovenous system is preferred.
Artificial kidney
One major problem will be the bulk or volume, and many of the systems developed up to now have been characterized by an unrealistic volume or weight. It might be a little euphemistic to call a device weighing 5 or 10 kg wearable. Factors that may induce an increase in weight may be: a) the presence of dialysate; b) the regeneration of dialysate or ultrafiltrate; c) the presence of pumps; d) the use of heparin pumps and other additional pumping systems; e) the computerized control and stearing of the process; f) the energy source. On the other hand, a decrease in weight may result in a loss of efficiency.
There is another pitfall: if blood flow to the dialyzer is too low, this may also have a negative influence on efficiency. It should be stressed that survival without complications in renal failure necessitates a small molecular clearance of 5 ml/min, i.e. a blood flow of at least 25 ml/min in a continuous system in the presence of a small molecular extraction or an ultrafiltration fraction of 20%. If the latter values are lower or if the system is discontinuous, the flow rate should even be higher.
Efficiency will also be too low if the available dialyzer surface is too small. The progressive development of a protein cake on the filtering membrane can cause a slow loss of efficiency in continuous systems, and further necessitates the research for perfectly biocompatible membrane materials.
The necessity of using small dialysate volumes may cause a further loss of efficiency if the dialysate becomes saturated with uremic solutes. Regeneration of dialysate may not be able to eliminate all toxic substances.
If ultrafiltration is used, one should be aware that a small molecular clearance of 5 ml/min corresponds to an ultrafiltration volume of at least 7 to 8 liters a day. This means that a large part of this fluid should be substituted if one does not want to end up with a dehydrated patient. Parenteral substitution will cause its own problems of equilibration; peroral substitution should result in a drinking regimen of 6 or 7 liters of a saline, potassium, magnesium and calcium containing solution per day. These points make the realisation of a system for ultrafiltrate regeneration more attractive, but here too homeostasis problems may occur.
A series of problems and possible pitfalls are due to the need of autoregulation and ultrafiltration control. Will it be possible to adapt the ultrafiltration rate to sudden changes in blood pressure or blood flow? Will it be possible to adapt the quantity of discarded ultrafiltrate to the hydration of the patient?
Ultrafiltration control may become additionally difficult in the case of dialysis or ultrafiltration with biocompatible high efficiency dialyzers, that all are characterized by a high compulsory ultrafiltration rate. Single needle dialysis of the pressure-pressure type allows perfect ultrafiltration control and may become a useful solution. A computerized and miniaturized control system may be an artificial organs centre project. Additionally, there is an urgent need for biocompatible high efficiency membranes with a low ultrafiltration coefficient. It is possible that dialysis with a wearable dialyzer causes damage to the blood cells due to shear and resistance in the tubings, but this problem will probably be of minor importance in view of the relatively low blood flows.
Temperature losses may occur, especially through dialysate and/or regenerated ultrafiltrate, but a heating system will again cause additional volume and weight.
A specific problem will be caused by the recharging of the dialyzer. It is difficult to believe that dialyzers will last forever, so it will be necessary to replace them underway in a sterile fashion. Similarly, other parts of the system, such as tubes, connections and eventual pumps and electronic material will need regular replacement without ill effects to the patient.
It may be necessary to computerize the whole system to allow adequate homeostasis, which will certainly add to the bulk of the system.
Lastly the question of cost will have to be raised as well as the extent that costs of conventional hemodialysis would be decreased or rather increased, especially if we go for high technology miniaturized systems.
Specific pitfalls of revolutionary new systems
The bionic artificial tubule is based on the use of tubular cells, grown on artificial capillary membranes, and used for the regeneration of ultrafiltrate. The biocompatibility of the membrane towards tubular cells may be a problem, and it is clear that the tubular cell will not stick to all membranes in the same way.
Another question is related to how long these cells will survive in a natural milieu, and how they will be replaced if they die. The natural tubular cell has two poles: a urine and a blood pole. Will this polarity remain present in these artificial tubules, and will the functional capacity of the cell be maintained?
Finally, one must also ask whether tubular cells will be reacting in a similar specific and differentiated way as in the living kidney.
Intestinal isolation as an artificial tubule may cause diarrhea, necessitates the release of ultrafiltrate in a contaminated milieu, and may become difficult to manipulate if an ultrafiltration volume of 8 liters is pursued in humans. If one is going for implantable systems in the future, biomaterials may become rejected by the human body.
All this however does not mention anything about the endocrine black box, i.e. the replacement by artificial systems of the kidney's endocrine functions.
Major steps have been made recently in the development of a wearable artificial kidney. They are associated with a number of potential pitfalls; especially the conflict between bulk of volume on one hand and efficiency on the other will become of major importance. These factors should be kept in mind in the future when further improvements are pursued.
